Abstract |
Pseudophypoparathyroidism (PHP) is characterized by hypocalcemia, hyperphosphatemia and elevated levels of parathyroid hormone (PTH) due to resistance to PTH. PHP type I a is caused by heterozygous inactivating mutation of the GNAS1 gene, which encodes signal transducer, Gsalpha. PHP type I a is associated with Albright's osteodystrophy (AHO). Those patients who have AHO phenotype without hormone resistance are affected by pseudopseudohypoparathyroidism.
|
Authors | Keiichi Ozono |
Journal | Clinical calcium
(Clin Calcium)
Vol. 17
Issue 8
Pg. 1214-9
(Aug 2007)
ISSN: 0917-5857 [Print] Japan |
PMID | 17660618
(Publication Type: Journal Article, Review)
|
Chemical References |
- Chromogranins
- Hydroxycholecalciferols
- GNAS protein, human
- GTP-Binding Protein alpha Subunits, Gs
- Calcitriol
- alfacalcidol
|
Topics |
- Calcitriol
(therapeutic use)
- Chromogranins
- Fibrous Dysplasia, Polyostotic
(genetics)
- GTP-Binding Protein alpha Subunits, Gs
(genetics)
- Humans
- Hydroxycholecalciferols
(therapeutic use)
- Mutation
- Pseudohypoparathyroidism
(diagnosis, drug therapy, genetics)
- Pseudopseudohypoparathyroidism
(genetics)
- Signal Transduction
|